首页 | 本学科首页   官方微博 | 高级检索  
检索        


The incidence of chylous ascites after liver transplantation and the proposal of a diagnostic and management protocol
Authors:Toshiharu Matsuura  Yusuke Yanagi  Makoto Hayashida  Yoshiaki Takahashi  Koichiro Yoshimaru  Tomoaki Taguchi
Institution:Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Abstract:

Background

No protocol has been established for the diagnosis and management of chylous ascites after liver transplantation (LT). In this study, we retrospectively reviewed our cases of posttransplant chylous ascites (PTCA) and aimed to propose a diagnostic and management protocol.

Patients and methods

We retrospectively reviewed the clinical records of 96 LT recipients who underwent LT at our department. The incidence of PTCA and the associated risk factors were analyzed and our protocol for chylous ascites was evaluated.

Results

PTCA occurred in 6 (6.3%) patients (mean age: 10.7 ± 11.0 years) at a mean of 10.8 ± 3.6 days after LT. The primary disease in all of PTCA cases was biliary atresia (BA). The periportal lymphadnopathy was an independent risk factor for PTCA. In all cases PTCA successfully resolved according to our protocol. Octreotide was administered in 4 of our 6 PTCA cases. The mean postoperative hospital stay was 40.2 ± 8.4 days, which was similar to that of cases without PTCA.

Conclusions

The incidence of PTCA in LT patients, especially in those with BA, is relatively high. Our diagnostic criteria and our management protocol were helpful for patients with refractory ascites after LT.

Type of study

Diagnostic test: Level II. Treatment study: Level III.
Keywords:ASR  ascites/serum ratio  BA  biliary atresia  CMV  cytomegalovirus  CT  computed tomography  GRWR  graft to recipient weight ratio  GV/SLV  graft volume to standard liver volume ratio  LDLT  living donor liver transplantation  LLS  left lateral segment  LT  liver transplantation  MCT  medium chain triglycerides  MELD  model for end-stage liver disease  NPO  nothing per oral  PELD  pediatric end-stage liver disease  PN  parenteral nutrition  PTCA  posttransplant chylous ascites  PV  portal vein  PVT  portal vein thrombosis  TG  triglyceride  TNC  total nucleated cell  TPN  total parenteral nutrition  Chylous ascites  Liver transplantation  Octreotide  Biliary atresia  Portal lymphadenopathy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号